A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
| Image |  |
|---|---|
| Description | scientific article published on 26 July 2010 |
| Author/s |
author: William Matsui Manuel Hidalgo |
| Publication date | July 26, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |